Asimov is a company specializing in the intelligent design of living systems, offering an integrated suite of cells, genes, and software to power advanced genetic design. They provide a comprehensive platform that integrates synthetic biology with computational tools to enable the design and manufacture of advanced therapies. Their product offerings include engineered host cells, a genetic parts library, and cloud-based design software for optimizing genetic systems across various applications, such as biologics, gene therapy, and programmable medicines. Asimov partners with biotech companies and pharmaceutical organizations to facilitate commercial-grade cell line development and therapeutic production.